Cita APA

Pan, Y., Xiao, W., Ye, F., Wang, H., Shen, Y., Yu, X., . . . Ren, S. (2021). Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion. Ann Transl Med.

Citación estilo Chicago

Pan, Yingying, et al. "Outcomes of Switching From Crizotinib to Alectinib in Patients With Advanced Non-small Cell Lung Cancer With Anaplastic Lymphoma Kinase Fusion." Ann Transl Med 2021.

Cita MLA

Pan, Yingying, et al. "Outcomes of Switching From Crizotinib to Alectinib in Patients With Advanced Non-small Cell Lung Cancer With Anaplastic Lymphoma Kinase Fusion." Ann Transl Med 2021.